Acurx Pharmaceuticals, Inc.
USD1.54
-0.14 (-8.04%)
CEO
David Luci
IPO Date
2021-06-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.64
Prev. Close
$1.68
Day Low
$1.54
Day High
$1.64
52W Low
$1.33
52W High
$11.72
Market Cap
$0.00B
Volume
0.08M
| $2.36 |
| 22 Apr 2026 | Donohue James J. | director | A-Award | Acquired | 2,150 | $2.36 |
| 22 Apr 2026 | HARRISON THOMAS L | director | A-Award | Acquired | 2,150 | $2.36 |
| 22 Apr 2026 | Scodari Joseph C | director | A-Award | Acquired | 2,150 | $2.36 |
| 22 Apr 2026 | DELUCCIA ROBERT J | director | A-Award | Acquired | 37,100 | $2.36 |
| 22 Apr 2026 | LUCI DAVID P | director, officer: President and CEO | A-Award | Acquired | 37,100 | $2.36 |
| 22 Apr 2026 | Shawah Robert G. | Chief Financial Officer | A-Award | Acquired | 25,900 | $2.36 |
| 6 Feb 2025 | DELUCCIA ROBERT J | director, 10 percent owner: | A-Award | Acquired | 250,000 | $0.80 |
| 6 Feb 2025 | LUCI DAVID P | director, 10 percent owner, officer: President and CEO | A-Award | Acquired | 250,000 | $0.80 |